top of page
Manufacturing and Developing Psychedelic Medicines to Unlock Neurologic Potential
Precision Fermentation
Scalable, sustainable, and economic manufacturing of psychedelic molecules
Drug
Development
Focused on commercially significant and overlooked unmet needs
Intellectual Property
Large intellectual property portfolio underpins accelerated timelines to market
Strategic
Partners
Partnered with Australia's most dynamic institutions, advisors and industry partners
We are focused on commercially significant opportunities
US$7 Billion
Psychedelic molecule production market by 2026
15%-20%
Of children have neurodevelopmental disorders
$68 Billion
Global neuro-degenerative disease market by 2027
Acknowledgement of Country
We acknowledgesthe Traditional Owners of the unceded land where we work and live. We pay our respects to Elders past, present and emerging. We celebrate the stories, culture and traditions of Aboriginal and Torres Strait Islanders of all communities who work and live on this land
bottom of page